First Eagle US I (FEVIX)

Nasdaq • Currently up 0.11 (+0.43%) in today's trading session

1 member of Congress has disclosed 5 trades in First Eagle US I (FEVIX) via STOCK Act filings. The most recent disclosure was a sale by Lloyd Doggett on 23 December 2014. Aggregate disclosed activity totals roughly $190.5K in purchases and $175K in sales (midpoint estimates from bracketed disclosure amounts).

First Eagle US I is currently trading at $25.52, positioned at 61% of its 52-week range ($23.55 – $26.80).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Automatically with eToro

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$25.52
24h Change
+0.11 (+0.43%)
52 Week Range
$23.55–$26.80
View on NASDAQ

First Eagle US I Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for FEVIX

Select to highlight on chart
5 transactions
Compliance: 0%
Lloyd Doggett23 Dec 201414 Jul 2015SaleStock$100,001 - $250,000N/A
Lloyd Doggett29 May 201414 Jul 2015PurchaseStock$50,001 - $100,000N/A
Lloyd Doggett28 May 201414 Jul 2015PurchaseStock$1,001 - $15,000N/A
Lloyd Doggett23 Oct 201314 Jul 2014PurchaseStock$15,001 - $50,000N/A
Lloyd Doggett13 Mar 201314 Jul 2014PurchaseStock$50,001 - $100,000N/A

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$1.61B

Volume

0

Beta

0.96

P/E Ratio

19.17

Fundamentals

EPS

$1.33

Div. Yield

8.83%

Open

$25.41

Day Range

$25.41 – $25.52

Company Information

Sector
Financial Services
Industry
Asset Management
Exchange
NASDAQ · USD
Country
US
IPO Date
2001-08-31
Website
www.firsteagle.com/funds/us-value-fund?t=fevix

Typically, at least 80% of the fund's net assets (including any capital obtained through borrowing for investment) are allocated to U.S.-based stocks and bonds. A smaller portion of the portfolio may also be directed towards non-U.S. securities. The...

No earnings data available for this stock.

Dividends

Dividend History

4 Dec 2025
Amount $2.2530
5 Dec 2024
Amount $1.4400
5 Dec 2023
Amount $1.3000
1 Dec 2022
Amount $1.5120
1 Dec 2021
Amount $1.9300
1 Dec 2020
Amount $0.3700
18 Dec 2019
Amount $1.5720
12 Dec 2018
Amount $2.7070
13 Dec 2017
Amount $1.8540
14 Dec 2016
Amount $1.7250
17 Dec 2015
Amount $0.9430
16 Dec 2014
Amount $1.3300
17 Dec 2013
Amount $0.9390
13 Dec 2012
Amount $0.5930
13 Dec 2011
Amount $0.6340
16 Dec 2010
Amount $0.3690
16 Dec 2009
Amount $0.2230
17 Dec 2008
Amount $0.3600
13 Dec 2007
Amount $1.0070
13 Dec 2006
Amount $0.9860
14 Dec 2005
Amount $0.5400
9 Dec 2004
Amount $0.5800
3 Dec 2003
Amount $0.6250
5 Dec 2002
Amount $0.5100

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about FEVIX

Which members of Congress have traded FEVIX?
1 member of Congress has disclosed 5 trade in First Eagle US I (FEVIX) under the STOCK Act: Lloyd Doggett.
When was FEVIX most recently disclosed by Congress?
The most recent FEVIX disclosure was a sale by Lloyd Doggett on 23 December 2014.
What is the total disclosed congressional trading volume for FEVIX?
Members of Congress have disclosed approximately $190.5K in FEVIX purchases and $175K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in FEVIX?
This FEVIX page updates as soon as new STOCK Act disclosures are filed for First Eagle US I. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.